Allison Portnoy
Biographic Data
| ID | 7580894 |
|---|---|
| NAME | Allison Portnoy |
| GIVEN NAMES | Allison |
| FAMILY NAME | Portnoy |
| SIGNATURE | PORTNOY A |
| AFFILIATIONS | Boston University |
| ORCID | 0000-0002-8467-1324 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Rebalancing power in infectious disease modelling
Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush
Many children do not receive a full schedule of childhood vaccines, yet there is limited evidence on the cost-effectiveness of strategies for improving vaccination coverage. Evidence is even scarcer on the cost-effectiveness of strategies for reaching ‘zero-dose children’, who have not received any routine vaccines. We evaluated the cost-effectiveness of periodic intensification of routine immunization (PIRI), a widely applied strategy for increa…
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
INTRODUCTION: One in two patients developing tuberculosis (TB) in low-income and middle-income countries (LMICs) faces catastrophic household costs. We assessed the potential financial risk protection from introducing novel TB vaccines, and how health and economic benefits would be distributed across income quintiles. METHODS: We modelled the impact of introducing TB vaccines meeting the World Health Organization preferred product characteristics…
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan
INTRODUCTION: Cervical cancer is the second most common cancer among women in Ethiopia, India, Nigeria and Pakistan. Our study objective was to assess similarities and differences in vaccine-impact projections through comparative modelling analysis by independently estimating the potential health impact of human papillomavirus (HPV) vaccination. METHODS: Using two widely published models (Harvard and Papillomavirus Rapid Interface for Modelling a…
Health gains and financial protection from human papillomavirus vaccination in Ethiopia
High out-of-pocket (OOP) medical expenses for cervical cancer (CC) can lead to catastrophic health expenditures (CHEs) and medical impoverishment in many low-resource settings. There are 32 million women at risk for CC in Ethiopia, where CC screening is extremely limited. An evaluation of the population health and financial risk protection benefits, and their distributional consequences across socioeconomic groups, from human papillomavirus (HPV)…
No prominent works on this page.
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan
INTRODUCTION: Cervical cancer is the second most common cancer among women in Ethiopia, India, Nigeria and Pakistan. Our study objective was to assess similarities and differences in vaccine-impact projections through comparative modelling analysis by independently estimating the potential health impact of human papillomavirus (HPV) vaccination. METHODS: Using two widely published models (Harvard and Papillomavirus Rapid Interface for Modelling a…
Health gains and financial protection from human papillomavirus vaccination in Ethiopia
High out-of-pocket (OOP) medical expenses for cervical cancer (CC) can lead to catastrophic health expenditures (CHEs) and medical impoverishment in many low-resource settings. There are 32 million women at risk for CC in Ethiopia, where CC screening is extremely limited. An evaluation of the population health and financial risk protection benefits, and their distributional consequences across socioeconomic groups, from human papillomavirus (HPV)…
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
INTRODUCTION: One in two patients developing tuberculosis (TB) in low-income and middle-income countries (LMICs) faces catastrophic household costs. We assessed the potential financial risk protection from introducing novel TB vaccines, and how health and economic benefits would be distributed across income quintiles. METHODS: We modelled the impact of introducing TB vaccines meeting the World Health Organization preferred product characteristics…
Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush
Many children do not receive a full schedule of childhood vaccines, yet there is limited evidence on the cost-effectiveness of strategies for improving vaccination coverage. Evidence is even scarcer on the cost-effectiveness of strategies for reaching ‘zero-dose children’, who have not received any routine vaccines. We evaluated the cost-effectiveness of periodic intensification of routine immunization (PIRI), a widely applied strategy for increa…
Rebalancing power in infectious disease modelling
Economic growth (4 works) · Environmental health (4 works) · Medicine (4 works) · Developing country (3 works) · Economics (3 works) · Vaccine Coverage and Hesitancy (3 works) · Business (2 works) · Cervical Cancer and HPV Research (2 works) · COVID-19 epidemiological studies (2 works) · Global Maternal and Child Health (2 works)